Freedom Investment Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Freedom Investment Management’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-11,785	Closed	-$434K	–	530
2014 Q1	$434K	Sell	11,785 -531	-4%	-$19.5K	0.09%	219
2013 Q4	$473K	Buy	12,316 +3,917	+47%	+$124K	0.12%	170
2013 Q3	$230K	Buy	+8,399	New	+$199K	0.07%	287

Other funds holding WX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Freedom Investment Management's WX Position: Q2 2014 in Review

Freedom Investment Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q2 2014, closing a stake of 11,785 shares — an estimated $434K sold.

Freedom Investment Management first reported a position in WX in Q3 2013 and held it in 3 quarters. The position peaked at $473K in Q4 2013. 154 funds tracked by Wall St. Rank hold WX as of Q2 2014.

Freedom Investment Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q2 2014 after selling out during the quarter.
Freedom Investment Management sold 11,785 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q2 2014, an estimated $434K.
Freedom Investment Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q3 2013 and held it in 3 quarters.
Freedom Investment Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $473K in Q4 2013.
154 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q2 2014.

Based on Freedom Investment Management's 13F filing for Q2 2014, filed 15 Aug 2014.